LONDON — Artemis Growth Partners, a global investment firm specializing in regulated medical cannabis and emergent medicinal therapeutics, appointed James Hayward as advisory director.
Hayward joins Artemis following a 35-year career at JPMorgan, where he founded and led JPMorgan’s European hedge fund credit business and worked closely with institutional investors through multiple economic and market cycles. His experience spans leveraged finance, high yield, credit derivatives, and distressed markets.
At Artemis, Hayward will work alongside co-founder and Chief Investment Officer William Muecke and Managing Partner E. Stanton McLean. He will advise the firm on capital formation, business development, LP relationships, and strategic financing initiatives across its global platform.
Hayward’s appointment comes as the global medical cannabis and emergent medicinal therapeutics markets enter a more mature phase of development. Regulatory frameworks are evolving, particularly across Europe, while investors are placing greater emphasis on governance, capital discipline, operating performance, and sustainable business models.
